Factors influencing left atrial volume in treated hypertension

Journal of Cardiology

Volumn 60, Issue 2, 2012, Pages 133-138

  Chen, Yuan ^a,b   Sato, Hirotomo ^a   Watanabe, Nobuhide ^a   Adachi, Tomoko ^a   Kodani, Nobuhiro ^a   Sato, Masatake ^a   Takahashi, Nobuyuki ^a   Kitamura, Jun ^a   Sato, Hidetoshi ^a   Yamaguchi, Kazuto ^a   Yoshitomi, Hiroyuki ^a   Tanabe, Kazuaki ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b Second Hospital Affiliated Ningxia Medicine University   (China)

Author keywords

Echocardiography; Hypertension; Left atrium; Left ventricular mass; Volume

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; BLOOD EXAMINATION; BODY MASS; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART VOLUME; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

AGED; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; CARDIOMEGALY; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; HYPERTENSION; MALE; ORGAN SIZE; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 84865387071     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.02.011     Document Type: Article

References (44)

1. Matsuda M., Matsuda Y. Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertension. Clin Cardiol 1996, 19:954-959.
2. Dreslinski G.R., Frohlich E.D., Dunn F.G., Messerli F.H., Suarez D.H., Reisin E. Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. Am J Cardiol 1981, 47:1087-1090.
3. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., Seward J.B. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002, 90:1284-1289.
4. Pritchett A.M., Mahoney D.W., Jacobsen S.J., Rodeheffer R.J., Karon B.L., Redfield M.M. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 2005, 45:87-92.
5. Barbier P., Alioto G., Guazzi M.D. Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1994, 24:165-170.
6. Cioffi G., Mureddu G.F., Stefenelli C., de Simone G. Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens 2004, 22:1589-1596.
7. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994, 271:840-844.
8. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., Roccella E.J. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
9. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
10. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
11. Ganau A., Devereux R.B., Pickering T.G., Roman M.J., Schnall P.L., Santucci S., Spitzer M.C., Laragh J.H. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990, 81:25-36.
12. de Simone G., Devereux R.B., Daniels S.R., Koren M.J., Meyer R.A., Laragh J.H. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995, 25:1056-1062.
13. Kircher B., Abbott J.A., Pau S., Gould R.G., Himelman R.B., Higgins C.B., Lipton M.J., Schiller N.B. Left atrial volume determination by biplane two-dimensional echocardiography: validation by cine computed tomography. Am Heart J 1991, 121:864-871.
14. Gutman J., Wang Y.S., Wahr D., Schiller N.B. Normal left atrial function determined by 2-dimensional echocardiography. Am J Cardiol 1983, 51:336-340.
15. Dewey F.E., Rosenthal D., Murphy D.J., Froelicher V.F., Ashley E.A. Does size matter? Clinical applications of scaling cardiac size and function for body size. Circulation 2008, 117:2279-2287.
16. Ilercil A., O'Grady M.J., Roman M.J., Paranicas M., Lee E.T., Welty T.K., Fabsitz R.R., Howard B.V., Devereux R.B. Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study. J Am Soc Echocardiogr 2001, 14:601-611.
17. Cioffi G., Mureddu G.F., Stefenelli C. Influence of age on the relationship between left atrial performance and left ventricular systolic and diastolic function in systemic arterial hypertension. Exp Clin Cardiol 2006, 11:305-310.
18. Bryg R.J., Williams G.A., Labovitz A.J. Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol 1987, 59:971-974.
19. Nikitin N.P., Witte K.K., Thackray S.D., Goodge L.J., Clark A.L., Cleland J.G. Effect of age and sex on left atrial morphology and function. Eur J Echocardiogr 2003, 4:36-42.
20. De Castro S., Caselli S., Di Angelantonio E., Del Colle S., Mirabelli F., Marcantonio A., Puccio D., Santini D., Pandian N.G. Relation of left atrial maximal volume measured by real-time 3D echocardiography to demographic, clinical, and Doppler variables. Am J Cardiol 2008, 101:1347-1352.
21. Salako B.L., Ogah O.S., Adebiyi A.A., Oladapo O.O., Aje A., Adebayo A.K., Ojji D.B., Ipadeola A., Nwafor C.E. Blood pressure control and left ventricular hypertrophy in hypertensive Nigerians. Ann Afr Med 2009, 8:156-162.
22. Gerdts E., Wachtell K., Omvik P., Otterstad J.E., Oikarinen L., Boman K., Dahlöf B., Devereux R.B. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007, 49:311-316.
23. Weber K.T., Brilla C.G., Campbell S.E., Guarda E., Zhou G., Sriram K. Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res Cardiol 1993, 88(Suppl. 1):107-124.
24. Burstein B., Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008, 51:802-809.
25. Shi Y., Li D., Tardif J.C., Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 2002, 54:456-461.
26. Li Y., Li W.M., Gong Y.T., Li B.X., Liu W., Han W., Dong D., Sheng L., Xue J.Y., Zhang L., Chu S., Yang B.F. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs. Basic Res Cardiol 2007, 102:245-256.
27. Healey J.S., Baranchuk A., Crystal E., Morillo C.A., Garfinkle M., Yusuf S., Connolly S.J. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005, 45:1832-1839.
28. Heckbert S.R., Wiggins K.L., Glazer N.L., Dublin S., Psaty B.M., Smith N.L., Longstreth W.T., Lumley T. Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population. Am J Hypertens 2009, 22:538-544.
29. Tsai C.T., Lai L.P., Kuo K.T., Hwang J.J., Hsieh C.S., Hsu K.L., Tseng C.D., Tseng Y.Z., Chiang F.T., Lin J.L. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008, 117:344-355.
30. Kato T., Yamashita T., Sekiguchi A., Tsuneda T., Sagara K., Takamura T., Kaneko S., Aizawa T., Fu L.T. Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling. J Cardiol 2011, 58:131-136.
31. Tanabe Y., Kawamura Y., Sakamoto N., Sato N., Kikuchi K., Hasebe N. Blood pressure control and the reduction of left atrial overload is essential for controlling atrial fibrillation. Int Heart J 2009, 50:445-456.
32. Pritchett A.M., Jacobsen S.J., Mahoney D.W., Rodeheffer R.J., Bailey K.R., Redfield M.M. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003, 41:1036-1043.
33. Vaziri S.M., Larson M.G., Benjamin E.J., Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994, 89:724-730.
34. Petersen P., Kastrup J., Brinch K., Godtfredsen J., Boysen G. Relation between left atrial dimension and duration of atrial fibrillation. Am J Cardiol 1987, 60:382-384.
35. Guazzi M., Arena R. Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol 2010, 7:648-659.
36. Redfield M.M., Jacobsen S.J., Burnett J.C., Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community appreciating the scope of the heart failure epidemic. JAMA 2003, 289:194-202.
37. Ferlinz J. Right ventricular performance in essential hypertension. Circulation 1980, 61:156-162.
38. Pedrinelli R., Canale M.L., Giannini C., Talini E., Penno G., Dell'Omo G., Di Bello V. Right ventricular dysfunction in early systemic hypertension: a tissue Doppler imaging study in patients with high-normal and mildly increased arterial blood pressure. J Hypertens 2010, 28:615-621.
39. McCullough P.A. B-type natriuretic peptide and its clinical implications in heart failure. Am Heart Hosp J 2004, 2:26-33.
40. Bettencourt P., Ferreira A., Dias P., Castro A., Martins L., Cerqueira-Gomes M. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology 2000, 93:19-25.
41. Sato Y., Fujiwara H., Takatsu Y. Biochemical markers in heart failure. J Cardiol 2012, 59:1-7.
42. Arques S., Jaubert M.P., Bonello L., Roux E., Armero S., Sbragia P., Nicoud A., Paganelli F. Usefulness of left atrial volume for the diagnosis of diastolic heart failure: an echocardiographic-catheterization study. Int J Cardiol 2010, 145:51-52.
43. Murakami Y., Shimada T., Inoue S., Shimizu H., Ohta Y., Katoh H., Nakamura K., Ishibashi Y. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy. Can J Cardiol 2002, 18:1294-1300.
44. Inoue S., Murakami Y., Sano K., Katoh H., Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000, 6:92-96.